ENLIGHT Annual Meeting 2015, Krakow, Poland
from
Friday 18 September 2015 (14:00)
to
Sunday 20 September 2015 (22:00)
Monday 14 September 2015
Tuesday 15 September 2015
Wednesday 16 September 2015
Thursday 17 September 2015
Friday 18 September 2015
14:00
Welcome and Introduction
-
Manjit Dosanjh
(
CERN
)
Pawel Olko
(
Institute of Nuclear Physics PAN
)
Welcome and Introduction
Manjit Dosanjh
(
CERN
)
Pawel Olko
(
Institute of Nuclear Physics PAN
)
14:00 - 14:30
14:30
Report from a meeting of European´s particle therapy center in Brussels and strategic consideration on evaluation and further development of particle therapy in Europe.
-
Michael Baumann
(
Dept. of Radiation Oncology at the University Hospital of Dresden
)
Report from a meeting of European´s particle therapy center in Brussels and strategic consideration on evaluation and further development of particle therapy in Europe.
Michael Baumann
(
Dept. of Radiation Oncology at the University Hospital of Dresden
)
14:30 - 15:00
15:00
Status of research and clinical trials at MIT and HIT
-
Juergen Debus
(
HIT
)
Status of research and clinical trials at MIT and HIT
Juergen Debus
(
HIT
)
15:00 - 15:30
15:30
The status of CNAO and clinical trials at CNAO.
-
Roberto Orecchia
(
CNAO
)
The status of CNAO and clinical trials at CNAO.
Roberto Orecchia
(
CNAO
)
15:30 - 16:00
16:30
The status of clinical trials in particle therapy in the USA.
-
Bhadrasain Vikram
(
National Cancer Institute
)
The status of clinical trials in particle therapy in the USA.
Bhadrasain Vikram
(
National Cancer Institute
)
16:30 - 17:00
17:00
The Status of MedAustron and clinical trials for particle therapy
-
Richard Poetter
(
Medical University of Vienna
)
Georg Dietmar
(
Medical University of Vienna
)
Thomas Schreiner
(
PEG MedAustron
)
The Status of MedAustron and clinical trials for particle therapy
Richard Poetter
(
Medical University of Vienna
)
Georg Dietmar
(
Medical University of Vienna
)
Thomas Schreiner
(
PEG MedAustron
)
17:00 - 17:30
17:30
Molecular tumour response to accelerated ions in Sweden and role of cellular modifying factors.
-
Rolf Lewenshon
(
Karolinska Institutet Radio Oncologist
)
Molecular tumour response to accelerated ions in Sweden and role of cellular modifying factors.
Rolf Lewenshon
(
Karolinska Institutet Radio Oncologist
)
17:30 - 18:00
Saturday 19 September 2015
09:00
The current status and challenges of detection and imaging in radiation therapy.
-
Alberto Del Guerra
(
Università di Pisa
)
The current status and challenges of detection and imaging in radiation therapy.
Alberto Del Guerra
(
Università di Pisa
)
09:00 - 09:30
09:30
Potential of J-PET technology for medical imaging.
-
Pawel Moskal
(
Jagiellonian University
)
Potential of J-PET technology for medical imaging.
Pawel Moskal
(
Jagiellonian University
)
09:30 - 10:00
10:00
Planning of intensity-modulated proton therapy based on variable relative biological effectiveness.
-
Radhe Mohan
(
MD Anderson Cancer Center
)
Planning of intensity-modulated proton therapy based on variable relative biological effectiveness.
Radhe Mohan
(
MD Anderson Cancer Center
)
10:00 - 10:30
11:00
France HADRON: benefits, challenges and future direction of a national collaboration.
-
Jacques Balosso
(
University Grenoble-Alpes
)
France HADRON: benefits, challenges and future direction of a national collaboration.
Jacques Balosso
(
University Grenoble-Alpes
)
11:00 - 11:30
11:30
Role of the International Strategy Committee in the LEIR initiative.
-
Philippe Lambin
(
Maastro
)
Steve Myers
(
CERN
)
Mike Waligorski
(
Cyfronet
)
Role of the International Strategy Committee in the LEIR initiative.
Philippe Lambin
(
Maastro
)
Steve Myers
(
CERN
)
Mike Waligorski
(
Cyfronet
)
11:30 - 12:00
12:00
EuCARD-2: Applications of Particle Accelerators in Europe (APAE) project.
-
Angeles Faus-Golfe
(
Instituto de Fisica Corpuscular (ES)
)
Manjit Dosanjh
(
CERN
)
EuCARD-2: Applications of Particle Accelerators in Europe (APAE) project.
Angeles Faus-Golfe
(
Instituto de Fisica Corpuscular (ES)
)
Manjit Dosanjh
(
CERN
)
12:00 - 12:30
14:00
Oral presentations of the 3 winning posters.
-
Julia Bauer
(
Heidelberg Ion Beam Therapy Center
)
Simona Giordanengo
(
INFN Torino
)
Mohammad Varasteh Anvar
(
INFN and University of Turin
)
Martyna Śniegocka
(
Jagiellonian University
)
Oral presentations of the 3 winning posters.
Julia Bauer
(
Heidelberg Ion Beam Therapy Center
)
Simona Giordanengo
(
INFN Torino
)
Mohammad Varasteh Anvar
(
INFN and University of Turin
)
Martyna Śniegocka
(
Jagiellonian University
)
14:00 - 14:45
14:45
Patient data and the role of ICTs in decision making.
-
Philippe Lambin
(
Patient data and the role of ICTs in decision making.
)
Patient data and the role of ICTs in decision making.
Philippe Lambin
(
Patient data and the role of ICTs in decision making.
)
14:45 - 15:15
15:15
The problem of the patient: Future challenges in particle therapy.
-
Tony Lomax
(
PSI
)
The problem of the patient: Future challenges in particle therapy.
Tony Lomax
(
PSI
)
15:15 - 15:45
15:45
ENLIGHT
-
Manjit Dosanjh
(
CERN
)
ENLIGHT
Manjit Dosanjh
(
CERN
)
15:45 - 16:15
16:15
Introduction to and Visit of Krakow’s Particle Therapy Centre.
-
Pawel Olko
(
Institute of Nuclear Physics PAN
)
Introduction to and Visit of Krakow’s Particle Therapy Centre.
Pawel Olko
(
Institute of Nuclear Physics PAN
)
16:15 - 17:30
Sunday 20 September 2015
09:00
Future Direction and Funding of Particle Therapy within the context of ENLIGHT & ESTRO
-
Richard Poetter
(
Medical University of Vienna
)
Future Direction and Funding of Particle Therapy within the context of ENLIGHT & ESTRO
Richard Poetter
(
Medical University of Vienna
)
09:00 - 12:00